Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
LABORATORIO REIG JOFRE ( (ES:RJF) ) has shared an announcement.
Reig Jofre has announced the execution of a capital increase through a ‘scrip dividend’ or flexible dividend, allowing shareholders to receive either free shares or cash equivalent to a dividend payment. This move, approved by the Board of Directors, aims to provide shareholders with multiple options for their dividends, potentially impacting the company’s capital structure and shareholder value.
More about LABORATORIO REIG JOFRE
LABORATORIO REIG JOFRE is a company operating in the pharmaceutical industry, focusing on the development and production of pharmaceutical products. The company is involved in providing innovative healthcare solutions and is committed to enhancing the well-being of its stakeholders.
Average Trading Volume: 34,395
Technical Sentiment Signal: Buy
Current Market Cap: €240.2M
For an in-depth examination of RJF stock, go to TipRanks’ Stock Analysis page.